🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

68 results for “Lxo Ireland Designated Activity Company” Clear

  1. Allo-depleted lymphocyte infusion

    Lxo Ireland Designated Activity Company

    Transplant-Related Hematologic Malignancy

    phase 1 other terminated

    1 trial

  2. CEA protein antigen plus BCG Vaccine Mix for percutaneous use

    Lxo Ireland Designated Activity Company

    Rectal Cancer

    phase 1 mab active

    1 trial

  3. COVID-19 Therapeutic Biologic Mix - NOVAVAX COVID-19 VACCINE plus BCG Vaccine Mix for percutaneous use

    Lxo Ireland Designated Activity Company

    Covid19

    phase 1 mab active

    1 trial

  4. Carfilzomib

    Lxo Ireland Designated Activity Company

    Acute Lymphoblastic Leukemia (ALL)

    phase 1 small molecule completed

    1 trial

  5. DT-216

    Lxo Ireland Designated Activity Company

    Friedreich Ataxia

    phase 1 small molecule completed

    2 trials

  6. GLA-AF

    Lxo Ireland Designated Activity Company

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  7. GLA-SE

    Lxo Ireland Designated Activity Company

    Merkel Cell Carcinoma

    phase 1 mab completed

    1 trial

  8. HIV Therapeutic Biologic Mix - HIV GP160 plus BCG Vaccine Mix for percutaneous use

    Lxo Ireland Designated Activity Company

    HIV Infections

    phase 1 mab active

    1 trial

  9. HSV 2 Formulation 1

    Lxo Ireland Designated Activity Company

    Genital Herpes

    phase 1 mab terminated

    1 trial

  10. ID-LV305

    Lxo Ireland Designated Activity Company

    Melanoma - Currently Enrolling

    phase 1 mab completed

    1 trial

  11. IDC-G305

    Lxo Ireland Designated Activity Company

    Melanoma

    phase 1 mab completed

    1 trial

  12. Infudopa i.v.

    Lxo Ireland Designated Activity Company

    Parkinson Disease

    phase 1 small molecule completed

    1 trial

  13. MSD-001

    Lxo Ireland Designated Activity Company

    Mental Health Disorders

    phase 1 small molecule completed

    1 trial

  14. Novel restraint

    Lxo Ireland Designated Activity Company

    Acute Respiratory Failure

    phase 1 other completed

    1 trial

  15. Switch active lifestyles brought to you by MediaWise

    Lxo Ireland Designated Activity Company

    Overweight

    phase 1 other completed

    1 trial

  16. Hyperbaric bupivacaine+Sufentanil

    Lxo Ireland Designated Activity Company

    Anesthesia; Functional

    approved small molecule completed

    1 trial

  17. Low intensity laser for oral mucositis

    Lxo Ireland Designated Activity Company

    Oral Mucositis

    approved other active

    1 trial

  18. Pre-dilation side branch

    Lxo Ireland Designated Activity Company

    Coronary Angiography

    approved other completed

    1 trial

  19. Roflumilast alternated days

    Lxo Ireland Designated Activity Company

    Chronic Obstructive Pulmonary Disease (COPD)

    approved small molecule completed

    1 trial

  20. Subcutaneous glargine insulin

    Lxo Ireland Designated Activity Company

    Diabetes Mellitus

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources